Related Experiment Videos

Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin

Eun-Ju Lee1, Minwha Jo, Seung Bae Rho

  • 1Molecular Therapy Research Center, Sungkyunkwan University, School of Medicine, Seoul 135-710, Korea.

International Journal of Cancer
|November 13, 2008
PubMed

Insights

Dickkopf-3 (Dkk3) acts as a tumor suppressor in cervical cancer by inhibiting the Wnt/beta-catenin pathway. Its downregulation, often due to promoter methylation, promotes cancer cell growth and is linked to cervical carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Wnt/beta-catenin pathway is crucial in keratinocyte malignant transformation in cervical cancer.
  • Dickkopf-1, -2, and -4 (Dkk1, Dkk2, Dkk4) are known modulators of this pathway.
  • The role of Dickkopf-3 (Dkk3) in cervical cancer and Wnt/beta-catenin signaling remains unclear.

Purpose of the Study:

  • To investigate the function of Dkk3 in cervical cancer.
  • To determine if Dkk3 expression is altered in cervical cancer tissues.
  • To elucidate the mechanism by which Dkk3 affects the Wnt/beta-catenin pathway.

Main Methods:

  • Gene expression analysis using cDNA microarray and real-time PCR.
  • DNA methylation studies on the Dkk3 promoter.
  • Functional assays including cell growth, colony formation, and luciferase reporter assays upon Dkk3 reintroduction.
  • Yeast two-hybrid screening to identify Dkk3 interacting partners.
  • Western blotting to assess protein levels and nuclear translocation of beta-catenin.

Main Results:

  • Dkk3 gene expression is frequently downregulated in cervical cancer tissues compared to normal tissues.
  • Dkk3 promoter methylation was observed in cervical cancer cell lines and patient samples, correlating with reduced Dkk3 mRNA levels.
  • Restoring Dkk3 expression in cervical cancer cells inhibited cell growth, colony formation, and beta-catenin signaling.
  • Beta-transducin repeat-containing protein (betaTrCP) was identified as a Dkk3-interacting partner, enhancing Dkk3's inhibitory effect on beta-catenin.
  • Dkk3 suppresses nuclear translocation of beta-catenin, downregulating downstream targets like VEGF and cyclin D.

Conclusions:

  • Dkk3 functions as a negative regulator of the Wnt/beta-catenin signaling pathway in cervical cancer.
  • Downregulation of Dkk3, often via promoter methylation, contributes to the activation of the beta-catenin pathway and cervical carcinogenesis.
  • Dkk3 represents a potential tumor suppressor and therapeutic target in cervical cancer.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...